Harmony Biosciences Reports Over 30% Revenue Growth, Eyes $720 Million in 2024
PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has recently revealed preliminary and unaudited growth of over 30% in net product revenue for the fourth quarter and full …
Harmony Biosciences Reports Over 30% Revenue Growth, Eyes $720 Million in 2024 Read More